Evidence map›Paper›PMID 26402917›Full record

ArticlePloS one2015

Sulforaphane Protects the Liver against CdSe Quantum Dot-Induced Cytotoxicity.

Wei Wang, Yan He, Guodong Yu, Baolong Li, Darren W Sexton, Thomas Wileman, Alexandra A Roberts, Chris J Hamilton, Ruoxi Liu, Yimin Chao and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Nrf2 in liver toxicology.Archives of pharmacal research · 2020
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Cadmium Protection Strategies--A Hidden Trade-Off?International journal of molecular sciences · 2016
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Wei WangNorwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.
Yan HeDepartment of Pathology, Harbin Medical University, Harbin, Heilongjiang, P. R. China.
Guodong YuNorwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.
Baolong LiCenter of Safety Evaluation of Drugs, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, P. R. China.
Darren W SextonNorwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.
Thomas WilemanNorwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.
Alexandra A RobertsSchool of Pharmacy, University of East Anglia, Norwich, Norfolk, United Kingdom.
Chris J HamiltonSchool of Pharmacy, University of East Anglia, Norwich, Norfolk, United Kingdom.
Ruoxi LiuSchool of Chemistry, University of East Anglia, Norwich, Norfolk, United Kingdom.
Yimin ChaoSchool of Chemistry, University of East Anglia, Norwich, Norfolk, United Kingdom.
Yujuan ShanSchool of Food Science and Engineering, Harbin Institute of Technology, Harbin, Heilongjiang, P. R. China.
Yongping BaoNorwich Medical School, University of East Anglia, Norwich, Norfolk, United Kingdom.
University of East Anglia · GBHarbin Institute of Technology · CNHarbin Medical University · CNHeilongjiang University of Chinese Medicine · CN

Funding

Biotechnology and Biological Sciences Research Council BB/H013504/1
6 · The paper itself

Abstract

The potential cytotoxicity of cadmium selenide (CdSe) quantum dots (QDs) presents a barrier to their use in biomedical imaging or as diagnostic and therapeutic agents. Sulforaphane (SFN) is a chemoprotective compound derived from cruciferous vegetables which can up-regulate antioxidant enzymes and induce apoptosis and autophagy. This study reports the effects of SFN on CdSe QD-induced cytotoxicity in immortalised human hepatocytes and in the livers of mice. CdSe QDs induced dose-dependent cell death in hepatocytes with an IC50 = 20.4 μM. Pre-treatment with SFN (5 μM) increased cell viability in response to CdSe QDs (20 μM) from 49.5 to 89.3%. SFN induced a pro-oxidant effect characterized by depletion of intracellular reduced glutathione during short term exposure (3-6 h), followed by up-regulation of antioxidant enzymes and glutathione levels at 24 h. SFN also caused Nrf2 translocation into the nucleus, up-regulation of antioxidant enzymes and autophagy. siRNA knockdown of Nrf2 suggests that the Nrf2 pathway plays a role in the protection against CdSe QD-induced cell death. Wortmannin inhibition of SFN-induced autophagy significantly suppressed the protective effect of SFN on CdSe QD-induced cell death. Moreover, the role of autophagy in SFN protection against CdSe QD-induced cell death was confirmed using mouse embryonic fibroblasts lacking ATG5. CdSe QDs caused significant liver damage in mice, and this was decreased by SFN treatment. In conclusion, SFN attenuated the cytotoxicity of CdSe QDs in both human hepatocytes and in the mouse liver, and this protection was associated with the induction of Nrf2 pathway and autophagy.

Indexed as

AdenineAndrostadienesAnimalsAutophagyCadmium CompoundsCell DeathCell LineGene Knockdown TechniquesGlutathioneHumansIntracellular Signaling Peptides and ProteinsIntracellular SpaceIsothiocyanatesKelch-Like ECH-Associated Protein 1LiverMetallothionein3-methyladenineAdenineAndrostadienesCadmium Compoundscadmium selenideGlutathioneIntracellular Signaling Peptides and ProteinsIsothiocyanatesKEAP1 protein, humanKelch-Like ECH-Associated Protein 1MetallothioneinNF-E2-Related Factor 2Protective AgentsRNA, MessengerSelenium CompoundssulforaphaneSulfoxidesWortmannin

Identifiers

PMID26402917
PMCPMC4581733
OpenAlexW1900483244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.